Mettler-Toledo International Inc (MTD)
被高估基本面
62
价格
$1486.44
市值
$30.96B
第一部分 · 这家公司值多少
概览
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 2026年9月19日 with claude-haiku-4-5 — shared with all users
Thermo Fisher supplies the same laboratory customers with overlapping lines of analytical instruments, pipettes and process analytics, and competes for the large multi-year supply contracts of pharmaceutical and biotech labs.
Agilent competes for the same analytical-chemistry budget in pharmaceutical and industrial quality-control labs, with chromatography, spectroscopy and lab software that substitute for Mettler-Toledo's analytical instruments.
Waters sells chromatography, mass spectrometry and thermal-analysis systems to the same regulated pharmaceutical and materials laboratories where Mettler-Toledo places its thermal analysis and titration instruments.
Through its life-sciences and diagnostics brands Danaher bids for the same laboratory and bioprocessing equipment, consumables and service contracts, often bundling them across global accounts.
Sartorius is the closest head-to-head rival in laboratory weighing, selling analytical and precision balances, pipettes and lab consumables to the same pharmaceutical, chemical and academic laboratories.
Shimadzu builds balances, moisture analyzers and analytical instruments for the same industrial and laboratory customers, and is the main rival for Mettler-Toledo in Japan and much of Asia.
资产负债表与流动性
营收
$4.13B
最近12个月（截至2026/6/30）
净利润
$906M
最近12个月（截至2026/6/30）
自由现金流
$849M
股东权益合计
$-24M
负债合计
$3.74B
流动比率
1.12
利息覆盖率
-
债务/EBITDA
1.66
每股收益
营收与净利润
自由现金流
收入构成
历史财务表
利润率变化
债务变化
债务负担有多重
增长一览表
增长 — 营业收入
公允价值估算
公允价值
$1181.36
当前价格
$1486.44
安全边际
-25.8%
公允价值区间
$820.70 - $1542.03
所用估值方法之间的离散区间，并非经过统计校准的置信区间。
估算方法
估值指标
市盈率（P/E）
34.06
ROE
-3677.4%
市净率（P/B）
2360.93
P/FCF
35.04
毛利率
60.3%
ROIC
-
盈利能力雷达图
价值创造（经济护城河）
ROIC
-
WACC
10.6%
ROIC − WACC
-
基本面分析标准
通过（17）
- EPS shows upward trend
- EPS CAGR 12.37%
- Price CAGR 11.95%
- Gross Margin 60.3%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 1816.3%
- Revenue Growth 5Y 5.5%
- Analyst Consensus 53% Buy
- Earnings Surprise avg 3.4%
- Earnings Quality (OCF/NI) 1.08
- Share Dilution -3.1%
- Net Margin Trend 21.9% vs 21.5%
- Piotroski F-Score 6/9
未通过（6）
- P/FCF 35.04
- P/B Ratio 2360.93
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- PEG Ratio 3.05
不可用（5）
- ROIC NaN%
- Dividend Payout NaN%
- Debt/Equity ratio
- Operating Margin NaN%
- Interest Coverage
Piotroski F-评分
信号混杂：部分领域需关注
盈利质量
高质量：盈利有现金流支撑
股权稀释
正在回购股份，对股东友好
机构持股
公司治理
管理团队
| 姓名 | 职位 | 年龄 |
|---|---|---|
| Mr. Patrick K. Kaltenbach | President & CEO | 62 |
| Mr. Shawn P. Vadala | Chief Financial Officer | 56 |
| Ms. Susan Graham-Bryce | Chief Human Resources Officer | 49 |
| Mr. Marc de La Gueronniere | Head of European & North American Market Organizations | 61 |
| Mr. Richard Wong | Head of Asia/Pacific | 59 |
| Mr. Markus Koepfli | Chief Information Officer | - |
| Mr. Adam William Uhlman | Head of Investor Relations | - |
| Ms. Michelle M. Roe | Chief Legal Officer & Corporate Secretary | 54 |
| Mr. Oliver Wittorf | Head of Product Inspection, Retail & Global Supply Chain | 49 |
| Mr. Gerhard Keller | Head of Process Analytics | 56 |
审计风险
2
董事会风险
1
薪酬风险
6
股东权利风险
5
第二部分 · 价格与买入时机
这一部分不判断公司是否值得拥有：它帮助你在基本面说服你之后，选择何时买入。包含：技术分析、潜力、历史回撤、Gamma 敞口。
损益历史
via SEC EDGAR
Latest News
Recent headlines for MTD, sourced from Markets Gazette.